Allarity Therapeutics Inc...

NASDAQ: ALLR · Real-Time Price · USD
0.95
-0.03 (-3.04%)
At close: Aug 15, 2025, 3:59 PM
0.99
3.98%
Pre-market: Aug 18, 2025, 04:13 AM EDT

Allarity Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 112K 112K 112K 112K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.07M
Cost of Revenue
1K 3K 12K 30K 47K 65K 60K 73K 97K 100K 112K 95K 53K 86K 70K 56K 56K
Gross Profit
-1K -3K 100K 82K 65K 47K -60K -73K -97K -100K -112K -95K -53K -86K -70K -56K 1.01M
Operating Income
-26.04M -27.24M -24.8M -16.92M -17.7M -17.12M -18.99M -19.13M -19.3M -33.95M -43.29M -41.92M -41.97M -26.12M -13.46M -12.01M -8.46M
Interest Income
755K 533K 317K 68K 18K 22K 30K 32K 34K 30K 19K 33K 28K 28K 28K 221K 221K
Pretax Income
-23.78M -24.9M -19.08M -12.67M -13.42M -12.92M -14.43M -13.9M -16.18M -17.13M -33.46M -27.16M -27.88M -26.62M -9.58M -12.29M -7.36M
Net Income
-23.97M -25.08M -19.35M -12.75M -13.5M -12.79M -13.91M -13.4M -15.67M -15.61M -33.44M -26.73M -27.47M -27.47M -6.93M -10.1M -5.21M
Selling & General & Admin
11.01M 11.44M 8.23M 9.12M 9.85M 10.02M 10.01M 9.09M 8.96M 9.74M 13.72M 14.78M 13.95M 12.15M 6.78M 5.12M 4.88M
Research & Development
5.33M 6.1M 6.86M 7.79M 7.84M 7.09M 5.42M 6.48M 6.77M 6.64M 14.56M 13.13M 14.01M 13.97M 7.68M 6.89M 4.61M
Other Expenses
9.7M 9.7M 9.7M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -201K -201K -201K -160.45K
Operating Expenses
26.04M 27.24M 24.79M 16.91M 17.69M 17.11M 15.43M 15.56M 15.74M 16.38M 28.28M 27.91M 27.96M 26.12M 14.46M 12.01M 9.53M
Interest Expense
608K 653K 808K 792K 508K 498K 384K 385K 276K 223K 455K 447K 667K 707K 401K 398K 145K
Selling & Marketing Expenses
n/a -2K -2K -2K -2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
23M 27.24M 24.8M 16.92M 17.7M 17.12M 15.43M 15.56M 15.74M 16.38M 28.28M 27.91M 27.96M 26.12M 14.46M 12.01M 9.53M
Income Tax Expense
-377K -381K -298K 70K 70K -137K -523K -509K -505K -1.52M -24K -435K -409K 851K -2.65M -2.2M -2.13M
Shares Outstanding (Basic)
1.11M 1.58M 1.5M 499.3K 5.84K 9.81K 4.12K 620.69 31.59 16.09 11.75 10.73 9.87 9.64 9.23 3.89 3.89
Shares Outstanding (Diluted)
1.11M 1.58M 1.58M 499.3K 5.84K 9.81K 4.12K 620.69 31.59 16.09 11.75 10.73 9.87 9.64 9.23 3.89 3.89
EPS (Basic)
-16.47 -713.05 -883.83 -2.22K -17.98K -123.53K -316.11K -883.46K -1.47M -1.84M -3.39M -2.97M -2.38M -2.11M -398.07K -256.02K -240.31K
EPS (Diluted)
-16.09 -712.67 -883.45 -2.22K -17.98K -123.53K -316.11K -883.46K -1.47M -1.84M -3.39M -2.97M -2.38M -2.11M -398.07K -256.02K -240.31K
EBITDA
-23.93M -24.64M -18.66M -10.77M -11.79M -11.28M -12.9M -13.44M -16.24M -17.26M -30.74M -27.05M -27.07M -25.65M -11.53M -11.85M -7.6M
EBIT
-20.5M -24.24M -18.27M -10.77M -11.8M -11.32M -12.94M -13.52M -16.35M -17.36M -33.78M -30.07M -30.21M -28.91M -11.85M -12.21M -7.84M
Depreciation & Amortization
2K 4K 12K 30K 47K 65K 60K 73K 97K 100K 112K 95K 50K 83K 3K 303K 346.55K